Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer
{{output}}
Head and neck cancer is the sixth leading cancer worldwide; head and neck squamous cell carcinoma (HNSCC) accounts for more than 90% of incident cases. In the US, cases of HNSCC associated with human papillomavirus (HPV) have been growing in proportion amongst... ...
